Back

HfpEF 2020: opportunities to intervene

21 May 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Directions in HFpEF research Chronic heart failure HFA Premium Access HEART FAILURE 2016

About the speaker

Photo
Professor Rudolf De Boer

Erasmus University Medical Centre, Rotterdam (Netherlands (The))

4 More presentations in this session

Presentation thumbnail
Na+/Ca2+ Exchanger (NCX) inhibition with ORM 11035 improves cardiac function and remodeling without lowering blood pressure in a model of heart failure with preserved ejection fraction
Professor F. Heinzel (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
A restrictive pattern of LV filling is only present in one third of cardiac AL amyloidosis patients
Associate Professor S. Perlini (Pavia, IT)
Abstract Slides Video
Presentation thumbnail
Dipeptidyl peptidase 4 inhibitor sitagliptin reduces oxidative stress, endothelial dysfunction and preserves diastolic function in a rat model of heart failure with preserved ejection fraction
Doctor K. Urbanek (Naples, IT)
Abstract
Presentation thumbnail
HFpEF and HFrEF display different anabolic phenotypes as assessed by IGF-1 and IGFBP-1
Doctor U. Ljung Faxen (Stockholm, SE)
Abstract Slides Video

Access the full session

Session thumbnail
Directions in HFpEF research

The Event

Event poster

HEART FAILURE 2016

21 May - 24 May 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources